These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 23990176)
1. Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Chen W; Li F; He C; Zhu Y; Tan W Ir J Med Sci; 2014 Jun; 183(2):283-91. PubMed ID: 23990176 [TBL] [Abstract][Full Text] [Related]
2. Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis. Manosroi W; Atthakomol P; Wattanawitawas P; Buranapin S Front Endocrinol (Lausanne); 2022; 13():870047. PubMed ID: 35432215 [TBL] [Abstract][Full Text] [Related]
3. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Matrozova J; Steichen O; Amar L; Zacharieva S; Jeunemaitre X; Plouin PF Hypertension; 2009 Apr; 53(4):605-10. PubMed ID: 19221213 [TBL] [Abstract][Full Text] [Related]
4. [Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension]. Deng YJ; Zhang SL; Liu PM; Mai LF; Tang JY; Yan L Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):743-749. PubMed ID: 27667270 [No Abstract] [Full Text] [Related]
5. Evaluation of insulin sensitivity and secretion in primary aldosteronism. Watanabe D; Yatabe M; Ichihara A Clin Exp Hypertens; 2016; 38(7):613-617. PubMed ID: 27669369 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of blood parameters related to lipid and glucose metabolism between two subtypes of primary aldosteronism. Zhu QG; Zhu F J Clin Hypertens (Greenwich); 2023 Jan; 25(1):13-21. PubMed ID: 36484331 [TBL] [Abstract][Full Text] [Related]
7. A possible association between primary aldosteronism and a lower beta-cell function. Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557 [TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. Catena C; Lapenna R; Baroselli S; Nadalini E; Colussi G; Novello M; Favret G; Melis A; Cavarape A; Sechi LA J Clin Endocrinol Metab; 2006 Sep; 91(9):3457-63. PubMed ID: 16822818 [TBL] [Abstract][Full Text] [Related]
9. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism. Zhang SL; Gao JW; Guo Y; Feng QL; Tang JY; Yan L; Wang JF; Cheng H; Liu PM Front Endocrinol (Lausanne); 2020; 11():547356. PubMed ID: 33101195 [No Abstract] [Full Text] [Related]
11. The prevalence of metabolic syndrome in primary aldosteronism and essential hypertension: A systematic review and meta-analysis. Sun K; Zhou C; Gong M; Zhang Y; Jiang Y; Song W J Clin Hypertens (Greenwich); 2024 Aug; 26(8):879-889. PubMed ID: 39037169 [TBL] [Abstract][Full Text] [Related]
12. [Incidence of metabolic disorders in patients with essential hypertension and patients with primary aldosteronism]. Gong YC; Guo RM; Chen SX; Chu SL; Guo JZ; Zhu DL Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):128-31. PubMed ID: 19099949 [TBL] [Abstract][Full Text] [Related]
13. Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion. Gerards J; Heinrich DA; Adolf C; Meisinger C; Rathmann W; Sturm L; Nirschl N; Bidlingmaier M; Beuschlein F; Thorand B; Peters A; Reincke M; Roden M; Quinkler M J Clin Endocrinol Metab; 2019 Aug; 104(8):3192-3202. PubMed ID: 30865224 [TBL] [Abstract][Full Text] [Related]
14. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Mortality for Patients of Primary Aldosteronism Compared With Essential Hypertension: A Systematic Review and Meta-Analysis. Meng Z; Dai Z; Huang K; Xu C; Zhang YG; Zheng H; Liu TZ Front Endocrinol (Lausanne); 2020; 11():121. PubMed ID: 32210920 [No Abstract] [Full Text] [Related]
16. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study. Huang X; Yu S; Xiao H; Pei L; Chen Y; Chen W; Li Y; Xiao H; Cao X Int J Endocrinol; 2021; 2021():6685469. PubMed ID: 34194493 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. Fallo F; Veglio F; Bertello C; Sonino N; Della Mea P; Ermani M; Rabbia F; Federspil G; Mulatero P J Clin Endocrinol Metab; 2006 Feb; 91(2):454-9. PubMed ID: 16291704 [TBL] [Abstract][Full Text] [Related]
19. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension. Hu Y; Zhang J; Liu W; Su X J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32163576 [TBL] [Abstract][Full Text] [Related]
20. Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism. Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chung SD; Endocrinol Metab (Seoul); 2020 Dec; 35(4):838-846. PubMed ID: 33261310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]